None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with first episode major depressive disorder as per DSM 5 criteria, with MADRS score grater than or equal to 19. Patients who are prescribed vortioxetine or escitalopram by the treating psychiatrist. The patient, who is willing and able to provide written informed consent.
Exclusion criteria
Exclusion criteria: Age less than 18 years or more than 60 years. Non consent for participation in the study. Patients who are not primarily diagnosed with major depressive disorder. Clinically significant endocrine, neurological or systemic illness (including hypo or hyperthyroidism, serious comorbid pulmonary, CNS, renal or hepatic disease, uncontrolled hypertension or diabetes). Patients with significant risk for suicide or MDD with psychotic features.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in HAM D, MADRS, CGI I, BC CCI score.Timepoint: Change in HAM D, MADRS, CGI I, BC CCI score at day 1, 14, 28 & 42 | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Dr M.K Shah Medical college and research institute